All the News
ALGENICS invited to speak at Gen2Bio, March 29, 2012
Saint-Herblain (France) – February 20, 2012 – Algenics announced that it will be presenting at Gen2Bio event to be held in Lorient (France), March 29, 2012.
ALGENICS to participate at BIO-Europe Spring, March 19-21, 2012
Saint-Herblain (France) – January 30, 2012 – Algenics announced that it will be participating at BIO-Europe Spring event to be held in Amsterdam (The Netherlands), March 19-21, 2012.
ALGENICS receives grant to support development of its microalgal protein expression technology for the production of monoclonal antibodies in oncology
Saint-Herblain (FRANCE) – January 30, 2012 – Algenics, the biopharmaceutical company offering a unique microalgae-based solution for the development of recombinant biotherapeutics, announced that it has received a grant from OSEO, the French innovation agency, with the support of the … Continue reading
ALGENICS to participate at B4B-Connection BIOPRODUCTION event, February 8-9, 2012
Saint-Herblain (France) – January 05, 2012. Algenics announced that it will be participating at the B4B-Connection BIOPRODUCTION event to be held in Evry Genopole® (France), February 8-9, 2012.
ALGENICS invited to speak at EABA Algae Biomass Conference and Expo, November 29-30, 2011
Saint-Herblain (France) – November 10 , 2011 – Algenics announced that it will be presenting at the EABA Algae Biomass Conference & Expo to be held in Brussels (Belgium), November 29-30, 2011.
ALGENICS announces €150 000 Participative Priming Loan from OSEO
Saint-Herblain (FRANCE) – September 22, 2011 – Algenics, the biopharmaceutical company offering a unique microalgae-based solution for the development of recombinant biotherapeutics, announced that it has obtained a €150 000 Participative Priming Loan (“Prêt Participatif d’Amorçage”) granted by OSEO, the … Continue reading
The September 15, 2011, issue of the French magazine “Usine Nouvelle” features an article on Algenics
Read the full article
ALGENICS and NOVIMMUNE announce a research collaboration to express fully human antibodies using the microalgal PTA cell line
Saint-Herblain (France) Plan-les-Ouates (Switzerland) – June 17, 2011. Algenics announced a new research collaboration with NovImmune to biomanufacture monoclonal therapeutic antibodies using its proprietary expression platform AlgebiosysTM. Two fully human therapeutic antibodies have been retained from NovImmune’s current pipeline to … Continue reading
ALGENICS to participate at Biomarine International Business Convention, September 7-9, 2011
Saint-Herblain (France) – June 16, 2011. Algenics announced that it will be participating at the Biomarine International Business Convention to be held in Nantes & Saint-Nazaire (France), September 7-9, 2011.